A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.


Updates from The Motley Fool

Latest updates on Merck & Co. from Fool.com.  The Fool has written over 1600 articles on Merck & Co..
Big Tech Is Taking on Diabetes

The combination of big tech and healthcare may be an unlikely matchup, but as these collaboration...



Stock Performance

View Interactive MRK Charts
Sponsored by

Key Data Points

Primary metrics and data points about Merck & Co..
Current Price: $61.84
Prev Close: $62.70
Open: $62.75
Bid: $61.62
Ask: $61.92
Day's Range: $61.81 - $63.02
52wk Range: $58.29 - $66.80
Volume: 8,953,819
Avg Vol 7,816,714
Market Cap: $169B
P/E (ttm): 33.89
EPS (ttm): $1.85
Div & Yield: $1.88 (3.0%)

Company Rating

What our community thinks about Merck & Co..
CAPS Rating 4 out of 5
 
2715 Outperform
218 Underperform
CAPS All Stars
 
627 Outperform
34 Underperform

How do you think Merck & Co. will perform against the market?



You pick for Merck & Co. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kenneth C. Frazier, CEO

81% Approve

Based on 826 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Merck & Co..

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers